Hepatotoxicity
This medicine may affect the liver.
Leaflet ROSUVASTATINA MSN LABORATORIES 20mg film-coated tablets
- Product code:
- W70982007
- Quantity:
- 30
- Indicated for:
- dyslipidemia
- Route of administration:
- oral
- Substance:
- rosuvastatin (statin lipid-lowering agent)
- ATC
- C10AA07 — Cardiovascular system | Lipid modifying agents | Lipid modifying agents, plain | Hmg coa reductase inhibitors
Precautions:
Major drug interactions
This medicine may have important interactions with other medicines.
Myopathy / rhabdomyolysis
Seek medical advice if unexplained muscle pain occurs.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Pregnancy warning
Use during pregnancy only on medical advice.
Rosuvastatin is a medication from the statin class, used to lower cholesterol levels and prevent cardiovascular diseases. It works by inhibiting the enzyme HMG-CoA reductase, which plays a key role in the production of cholesterol in the liver. By reducing LDL cholesterol ('bad cholesterol') and increasing HDL cholesterol ('good cholesterol'), rosuvastatin helps prevent the buildup of atherosclerotic plaques in the arteries.
This medication is indicated for patients with primary hypercholesterolemia, mixed dyslipidemia, or hypertriglyceridemia, as well as for the prevention of cardiovascular events in high-risk individuals, such as those with a history of myocardial infarction, stroke, or diabetes. It is also used to slow the progression of atherosclerosis.
Rosuvastatin is taken orally, usually once daily, and the dose is adjusted based on cholesterol levels and the patient's response to treatment. It is important for patients to follow a low-fat, low-cholesterol diet while on this medication. Regular monitoring of liver function and lipid levels is essential to ensure the treatment's effectiveness and safety.
Common side effects include muscle pain, nausea, headache, and abdominal discomfort. In rare cases, more serious reactions such as rhabdomyolysis (a condition involving muscle tissue breakdown) or liver dysfunction may occur. Rosuvastatin treatment should be supervised by a doctor, and patients should report any unusual symptoms.
This medication is indicated for patients with primary hypercholesterolemia, mixed dyslipidemia, or hypertriglyceridemia, as well as for the prevention of cardiovascular events in high-risk individuals, such as those with a history of myocardial infarction, stroke, or diabetes. It is also used to slow the progression of atherosclerosis.
Rosuvastatin is taken orally, usually once daily, and the dose is adjusted based on cholesterol levels and the patient's response to treatment. It is important for patients to follow a low-fat, low-cholesterol diet while on this medication. Regular monitoring of liver function and lipid levels is essential to ensure the treatment's effectiveness and safety.
Common side effects include muscle pain, nausea, headache, and abdominal discomfort. In rare cases, more serious reactions such as rhabdomyolysis (a condition involving muscle tissue breakdown) or liver dysfunction may occur. Rosuvastatin treatment should be supervised by a doctor, and patients should report any unusual symptoms.
General data about ROSUVASTATINA MSN LABORATORIES 20mg
- Substance:
- rosuvastatin
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W70982007
- Concentration:
- 20mg
- Pharmaceutical form:
- film-coated tablets
- Quantity:
- 30
- Product type:
- Generic medicine
- Price:
- 49.01 RON
- Prescription status:
- P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Pharmaceutical forms available for rosuvastatin
Concentrations available for rosuvastatin
- 10mg
- 15mg
- 20mg
- 30mg
- 40mg
- 5mg
Compensation lists for ROSUVASTATINA MSN LABORATORIES 20mg MSN Labs Europe
B - Sublist B with 50% discount from the reference price
- Price
- 49.01 RON
- Copayment
- 24.50 RON
- Patient
- 24.51 RON